Last update:

Oncology & Cancer news

Oncology & Cancer

Stevia leaf extract has potential as anticancer treatment, researchers find

Stevia may provide more benefits than as a zero-calorie sugar substitute. When fermented with bacteria isolated from banana leaves, stevia extract kills off pancreatic cancer cells but doesn't harm healthy kidney cells, according ...

Oncology & Cancer

Human-specific genes that shaped human intelligence may fuel cancer

A study led by Dr. Li Chuanyun from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences (CAS) has revealed how recently evolved human-specific genes—critical for brain development and ...

Oncology & Cancer

Novel complex induces immunogenic cancer cell death

Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such a clever manner that they raise a red flag as they die. They signal to the immune system that something ...

Oncology & Cancer

How metabolic chatter between cells undermines anti-tumor immunity

A Ludwig Cancer Research study has identified a complex chain of molecular chatter by which cancer cells, exploiting ordinary metabolic processes, program one set of noncancerous cells to manipulate another set of such cells ...

Oncology & Cancer

A new framework for understanding and tackling CAR T toxicities

Immunotherapy using CAR T cells is finding ever more applications. In addition to their use in the treatment of blood and lymphatic cancers, CAR T cells are now also being investigated for solid tumors and various autoimmune ...

Oncology & Cancer

Trove of genetic data to spur cancer research released

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a pancreatic cancer cell. Scientists ...

Oncology & Cancer

Study sheds light on enzyme's role in driving lymphoma growth

A study led by University of Cincinnati Cancer Center researchers sheds new light on the mechanisms by which a major oncogene promotes and sustains lymphoma development and progression, paving the way for novel targeted therapies.

Oncology & Cancer

Low alcohol use disorder treatment rates seen in cancer survivors

For U.S. adult cancer survivors with a new alcohol use disorder (AUD) diagnosis, the one-year cumulative incidence of AUD treatment initiation was 14.3%, according to a research letter published online May 27 in the Annals ...

Oncology & Cancer

Mapping lifelong chronic health risks for childhood cancer survivors

Children are much more likely to survive cancer today than 50 years ago. Unfortunately, as adults, many of them develop cardiovascular disease, secondary cancers, or both, believed to result from the toxic effects of chemotherapy ...

Medications

New biomarker may guide best use of KRAS inhibitors in lung cancer

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC), ...

Oncology & Cancer

What is Mohs micrographic surgery? 8 FAQs about Mohs

One in five Americans is likely to get skin cancer in their lifetime, making it the most common type of cancer in the U.S. But the good news is that it's highly treatable when caught early, especially if it can be treated ...

Oncology & Cancer

Gut bacteria may hold key to unlocking better cancer treatment

Scientists have discovered a range of "biomarkers" that could help to improve detection and treatment of gastrointestinal diseases (GIDs) such as gastric cancer (GC), colorectal cancer (CRC), and inflammatory bowel disease ...